Tianjin Eye Hospital Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2020
NCT04667819
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Tianjin Eye Hospital

Active Ingredients

Drugs in Other Trials (2)

atropine (1 trial)

hyaluronic acid (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 2